FREEZE Cohort Study

NCT01360008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4071

Last updated 2019-06-27

No results posted yet for this study

Summary

Safety and efficacy in radiofrequency (RF) or cryoballoon atrial fibrillation (AF) ablation will be investigated in a cohort study design in experienced electrophysiologic (EP) centers analyzing propensity-matched cohorts.

Conditions

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Ellen Hoffmann, MD · Klinikum Bogenhausen, München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2016-01-31
Completion
2017-04-30

Countries

  • United States
  • Austria
  • Germany
  • Greece
  • South Africa
  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01360008 on ClinicalTrials.gov